Factors influencing long-term outcome of infliximab treatment in Crohn's disease

被引：0
|
作者：
Sachdev, R
Banks, PA
Wolf, JL
Strate, LL
Friedman, S
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)82667-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A527 / A527
页数：1
相关论文
共 50 条
  • [21] Association of Serum Infliximab and Antibodies to Infliximab to Long-Term Clinical Outcome and Mucosal Healing in Crohn's Disease
    Ben-Bassat, Ofer
    Romanova, Anna
    Iacono, Anna
    Irwin, Sue P.
    Greenberg, Gordon R.
    GASTROENTEROLOGY, 2013, 144 (05) : S775 - S775
  • [22] Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
    Schnitzler, Fabian
    Fidder, Herma
    Ferrante, Marc
    Noman, Maja
    Arijs, Ingrid
    Van Assche, Gert
    Hoffman, Ilse
    Van Steen, Kristel
    Vermeire, Severine
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (09) : 1295 - 1301
  • [23] Long-term Outcomes With Infliximab Treatment in Children With Crohn's Disease at a Single Centre
    Church, Peter
    Guan, Jack
    Salz, Liad
    Frost, Karen
    Muise, Aleixo
    Walters, Thomas
    Griffiths, Anne
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S5 - S6
  • [24] Long-term Outcomes With Infliximab Treatment in Children With Crohn's Disease at a Single Centre
    Church, Peter
    Guan, Jack
    Salz, Liad
    Frost, Karen
    Muise, Aleixo
    Walters, Thomas
    Griffiths, Anne
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S72 - S73
  • [25] The Course of Infliximab Discontinuation After Long-Term Maintenance Treatment in Crohn's Disease
    Armuzzi, Alessandro
    Rizzi, Marina
    Monterubbianesi, Rita
    Marzo, Manuela
    Cicala, Michele
    Guidi, Luisa
    Prantera, Cosimo
    Kohn, Anna
    GASTROENTEROLOGY, 2010, 138 (05) : S687 - S687
  • [26] An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease
    Arnott, IDR
    McNeill, G
    Satsangi, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (12) : 1451 - 1457
  • [27] Long-term outcome of treatment with infliximab in 440 crohn's disease patients: Results from a single center cohort
    Schnitzler, Fabian
    Fidder, Henna
    Ferrante, Marc
    Noman, Maja
    Van assche, Geri
    Hoffman, Ilse
    Vermeire, Severine
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2007, 132 (04) : A145 - A145
  • [28] Long-term Outcome of Treatment with Infliximab in Pediatric-onset Crohn's Disease: A Population-Based Study
    Crombe, Valerie
    Salleron, Julia
    Savoye, Guillaume
    Dupas, Jean-Louis
    Vernier-Massouille, Gwenola
    Lerebours, Eric
    Cortot, Antoine
    Merle, Veronique
    Vasseur, Francis
    Turck, Dominique
    Gower-Rousseau, Corinne
    Lemann, Marc
    Colombel, Jean-Frederic
    Duhamel, Alain
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (10) : 2144 - 2152
  • [29] LONG-TERM OUTCOME OF TREATMENT WITH INFLIXIMAB (IFX) IN PEDIATRIC CROHN'S DISEASE (CD): A POPULATION-BASED STUDY
    Crombe, V.
    Salleron, J.
    Savoye, G.
    Dupas, J.
    Vernier-Massouille, G.
    Lerebours, E.
    Cortot, A.
    Turck, D.
    Gower-Rousseau, C.
    Lemann, M.
    Colombel, J.
    Duhamel, A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E114 - E115
  • [30] Factors Influencing Mucosal Healing in Crohn's Disease during Infliximab Treatment
    Tursi, Antonio
    Elisei, Walter
    Giorgetti, Gian Marco
    Penna, Antonio
    Picchio, Marcello
    Brandimarte, Giovanni
    HEPATO-GASTROENTEROLOGY, 2013, 60 (125) : 1041 - 1046
12345